Detection of circulating tumour cells with the magnetic activated cell sorter

A technique has been developed for the detection of tumour cells in blood with the magnetic activated cell sorter (MACS). Colonic carcinoma cell lines and disaggregated primary tumours were used to establish optimal conditions of separation. A murine monoclonal antibody specific for epithelial cells was added to the suspension of leucocytes and tumour cells, followed by magnetic labelled goat antimouse antibody. The labelled tumour cells were retrieved by passing this suspension through a MACS separation column in a strong magnetic field. Tumour cells were detected at a dilution of 10 cells per ml blood. Tumour cells were identified in mesenteric blood in three of 24 patients undergoing surgery for colorectal cancer. This study supports the use of the MACS to detect circulating tumour cells.

[1]  D. Allen,et al.  Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS). , 1993, Cytometry.

[2]  G. Kocjan,et al.  Detection and enumeration of circulating tumour cells in colorectal cancer , 1993, The British journal of surgery.

[3]  M. Moutschen,et al.  Efficient immunoselection of cytolytic effectors with a magnetic cell sorter. , 1993, Research in immunology.

[4]  R. Rees,et al.  Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. , 1992, British journal of urology.

[5]  U. Bagge,et al.  Lethal deformation of cancer cells in the microcirculation: A potential rate regulator of hematogenous metastasis , 1992, International journal of cancer.

[6]  L. Weiss,et al.  Ber‐EP4 Antibody as a Discriminant in the Differential Diagnosis of Malignant Mesothelioma Versus Adenocarcinoma , 1991, The American journal of surgical pathology.

[7]  H. Stein,et al.  Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. , 1990, Journal of clinical pathology.

[8]  Andreas Radbruch,et al.  High gradient magnetic cell separation with MACS. , 1990, Cytometry.

[9]  E. Mayhew,et al.  Quantitation of tumorigenic disseminating and arrested cancer cells. , 1984, British Journal of Cancer.

[10]  D. Glaves.  Role of polymorphonuclear leukocytes in the pulmonary clearance of arrested cancer cells. , 1983, Invasion & metastasis.

[11]  D. Glaves.  Metastasis: Reticuloendothelial system and organ retention of disseminated malignant cells , 1980, International journal of cancer.

[12]  P. Whittle,et al.  Further studies on the industrial melanic moth Biston betularia (L.) in the northwest of the British Isles , 1976, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[13]  A. Salsbury.  The significance of the circulating cancer cell. , 1975, Cancer treatment reviews.

[14]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[15]  Mcgrew Ea.  CRITERIA FOR THE RECOGNITION OF MALIGNANT CELLS IN CIRCULATING BLOOD. , 1965 .

[16]  Engell Hc.  [Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation]. , 1955 .

[17]  E. H. Pool,et al.  Cancer Cells in the Blood Stream , 1934 .